|
SMS Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
2840.85 Cr.
|
P/BV
|
3.90
|
Book Value (Rs.)
|
82.21
|
|
52 Week High/Low (Rs.)
|
360/176
|
FV/ML
|
1/1
|
P/E(X)
|
41.09
|
|
Bookclosure
|
22/09/2025
|
EPS (Rs.)
|
7.80
|
Div Yield (%)
|
0.12
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Gross] | 831.29 | 748.20 | 519.75 | 550.48 | 605.07 |
| Less: Excise/Sevice Tax/Other Levies | 52.01 | 41.74 | 0.00 | 35.47 | 44.26 |
| Revenue From Operations [Net] | 779.27 | 706.46 | 519.75 | 515.02 | 560.82 |
| Other Operating Revenues | 3.47 | 2.81 | 2.30 | 4.86 | 2.36 |
| Total Operating Revenues | 782.75 | 709.26 | 522.05 | 519.87 | 563.18 |
| | | | | | |
| Other Income | 6.22 | 4.46 | 4.89 | 5.20 | 3.45 |
| Total Revenue | 788.97 | 713.72 | 526.94 | 525.07 | 566.63 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 501.87 | 425.26 | 299.73 | 387.95 | 313.27 |
| Operating And Direct Expenses | 86.35 | 73.44 | 57.31 | 55.04 | 39.39 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -64.81 | -1.00 | 36.08 | -112.50 | 26.73 |
| Employee Benefit Expenses | 80.08 | 64.15 | 55.04 | 51.02 | 41.17 |
| Finance Costs | 18.54 | 23.46 | 21.92 | 18.88 | 11.16 |
| Depreciation And Amortisation Expenses | 34.34 | 31.52 | 32.13 | 32.15 | 22.28 |
| Other Expenses | 40.26 | 30.79 | 19.37 | 24.03 | 21.50 |
| Total Expenses | 696.64 | 647.62 | 521.59 | 456.57 | 475.51 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 92.34 | 66.11 | 5.35 | 68.50 | 91.12 |
| | | | | | |
| Profit/Loss Before Tax | 92.34 | 66.11 | 5.35 | 68.50 | 91.12 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 19.90 | 15.00 | 0.06 | 15.00 | 16.00 |
| Deferred Tax | 5.30 | 1.78 | 1.47 | -0.08 | 14.11 |
| Tax For Earlier Years | -0.26 | 0.13 | -0.06 | -14.30 | 0.05 |
| Total Tax Expenses | 24.94 | 16.91 | 1.47 | 0.62 | 30.16 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 67.40 | 49.20 | 3.88 | 67.88 | 60.96 |
| | | | | | |
| Profit/Loss From Continuing Operations | 67.40 | 49.20 | 3.88 | 67.88 | 60.96 |
| | | | | | |
| Profit/Loss For The Period | 67.40 | 49.20 | 3.88 | 67.88 | 60.96 |
| | | | | | |
| Minority Interest | 0.00 | 0.00 | -10.94 | -5.66 | 0.00 |
| Share Of Profit/Loss Of Associates | 1.74 | 0.63 | 0.00 | 0.00 | 1.56 |
| Consolidated Profit/Loss After MI And Associates | 69.14 | 49.83 | -7.06 | 62.22 | 62.53 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 8.16 | 5.89 | -0.83 | 7.35 | 7.39 |
| Diluted EPS (Rs.) | 8.16 | 5.89 | -0.83 | 7.35 | 7.39 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 3.39 | 2.54 | 2.54 | 2.54 | 0.00 |
